These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6355726)

  • 1. Dapsone-resistant leprosy in Burundi.
    Bourland J; Van Loo L; Pattyn SR
    Lepr Rev; 1983 Sep; 54(3):239-42. PubMed ID: 6355726
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on dapsone-resistant Mycobacterium leprae in leprosy patients of Gudiyatham Taluk, the leprosy control area of the Schieffelin Leprosy Research and Training Centre, Karigiri. 2. A progress report.
    Almeida JG; Christian M; Chacko CJ; Taylor PM; Fritschi EP
    Lepr Rev; 1983 Sep; 54(3):185-91. PubMed ID: 6355722
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevalence of dapsone-resistant leprosy in Burundi. Temporary results].
    Bourland J; Van Loo L; Pattyn SR
    Acta Leprol; 1982; (86-87):29-33. PubMed ID: 6815995
    [No Abstract]   [Full Text] [Related]  

  • 4. Secondary dapsone-resistant leprosy in Shanghai Municipality.
    Ji BH; Chen JK; Zhang JL; Hou YH; Ni GX; Zhang RB
    Lepr Rev; 1983 Sep; 54(3):197-202. PubMed ID: 6355724
    [No Abstract]   [Full Text] [Related]  

  • 5. Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.
    Levy L; Shepard CC; Fasal P
    Am J Trop Med Hyg; 1972 May; 21(3):315-21. PubMed ID: 4554496
    [No Abstract]   [Full Text] [Related]  

  • 6. Dapsone-resistant leprosy in a population of Bamako (Mali).
    Baquillon G; Ferracci C; Saint Andre P; Pattyn SR
    Lepr Rev; 1980 Dec; 51(4):315-9. PubMed ID: 7012500
    [No Abstract]   [Full Text] [Related]  

  • 7. Dapsone-resistant leprosy and its implications for leprosy control programmes.
    Pearson JM; Cap JA; Haile GS; Rees RJ
    Lepr Rev; 1977 Jun; 48(2):83-94. PubMed ID: 331000
    [No Abstract]   [Full Text] [Related]  

  • 8. Dapsone-resistant leprosy in Jakarta: a preliminary report.
    Utji R; Kosasih A; Santoso AU
    Lepr Rev; 1983 Sep; 54(3):193-5. PubMed ID: 6355723
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of secondary dapsone-resistant leprosy in Upper Volta.
    Pattyn SR; Yada A; Sansarricq H; van Loo L
    Lepr Rev; 1984 Dec; 55(4):361-7. PubMed ID: 6396476
    [No Abstract]   [Full Text] [Related]  

  • 10. Dapsone-resistant Mycobacterium leprae in a patient receiving dapsone in low doses.
    Browne SG
    Int J Lepr Other Mycobact Dis; 1969; 37(3):296-301. PubMed ID: 4906048
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary dapsone-resistant leprosy.
    Pearson JM; Haile GS; Rees RJ
    Lepr Rev; 1977 Jun; 48(2):129-32. PubMed ID: 330999
    [No Abstract]   [Full Text] [Related]  

  • 12. Ulcerating lepromatous leprosy in a patient with dapsone-resistant Mycobacterium leprae.
    McDougall AC; Rees RJ
    Lepr Rev; 1973 Jun; 44(2):59-64. PubMed ID: 4582180
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical assessment and management of dapsone-resistant leprosy for the field worker.
    Warren G
    Lepr Rev; 1977 Jun; 48(2):113-21. PubMed ID: 330996
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined clofazimine- and dapsone-resistant leprosy. A case report.
    Kar HK; Bhatia VN; Harikrishnan S
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies.
    Rees RJ; Waters MF; Pearson JM; Helmy HS; Laing AB
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):159-69. PubMed ID: 776852
    [No Abstract]   [Full Text] [Related]  

  • 16. Primary dapsone-resistant leprosy in Cebu, Philippines.
    Guinto RS; Cellona RV; Fajardo TT; de la Cruz EC
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):427-30. PubMed ID: 7042607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of dapsone-resistant leprosy in Israel.
    Levy L; Rubin GS; Sheskin J
    Lepr Rev; 1977 Jun; 48(2):107-12. PubMed ID: 330995
    [No Abstract]   [Full Text] [Related]  

  • 18. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411
    [No Abstract]   [Full Text] [Related]  

  • 19. Does dapsone resistance really matter in the MDT era?
    Ji B
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):54-5. PubMed ID: 11480322
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: Sulphone resistance in leprosy.
    Browne SG
    Lancet; 1975 Jul; 2(7926):177. PubMed ID: 49763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.